- Presentations
- 0
- Brands
- 0
- Manufacturers
- 0
- Available from stock
- 0
Insulin aspart and Insulin degludec is a medicine. It is available for export supply from India to licensed hospitals, importers and physicians, with the documents the destination country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- ATC classification
- A10AD06 Insulin degludec · Insulin analog, subgroup A10AD
- US FDA first approval
- 25 September 2015
- EU status
- Authorised
- Orphan designation
- No
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Fixed-dose combination of
- Insulin aspart, Insulin degludec
All presentations
No presentations of Insulin aspart and Insulin degludec are listed yet. Ask us to source it
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
Questions and answers
Is Insulin aspart and Insulin degludec available for export from India?
No presentation of Insulin aspart and Insulin degludec is listed yet, but our sourcing team can check licensed channels. Send a request with the strength, quantity and destination country.
Is Insulin aspart and Insulin degludec approved by the US FDA?
Yes. The US FDA first approved Insulin aspart and Insulin degludec on 25 September 2015, according to Drugs@FDA.
Is Insulin aspart and Insulin degludec authorised in the European Union?
Yes. Insulin aspart and Insulin degludec has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.
Does Insulin aspart and Insulin degludec need cold chain shipping?
No listed presentation of Insulin aspart and Insulin degludec is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Which ATC class is Insulin aspart and Insulin degludec in?
Insulin aspart and Insulin degludec is classified under ATC code A10AD06 (Insulin degludec).
References
- Ryzodeg: European public assessment report (EPAR). European Medicines Agency. Retrieved 4 March 2025
Request Insulin aspart and Insulin degludec for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.